Silk Technologies, Ltd.
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
0
Ending by 2030
Aug 2035
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due May 12, 2027The maintenance fee for Fibroin-derive protein composition (US 10,471,128) comes due May 12, 2027. Unpaid by Nov 12, 2027, it lapses early.
- 1 fee due Aug 6, 2027The maintenance fee for Fibroin-derived protein composition (US 11,890,328) comes due Aug 6, 2027. Unpaid by Feb 7, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 7 of 7
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,394,355 | Fibroin-derived protein composition In force · From the USPTO record | In force | From the USPTO record | |
| US 9,907,836 | Fibroin-derived protein composition In force · From the USPTO record | In force | From the USPTO record | |
| US 10,471,128 | Fibroin-derive protein composition In force · From the USPTO record | In force | From the USPTO record | |
| US 11,045,524 | Fibroin-derived protein composition In force · From the USPTO record | In force | From the USPTO record | |
| US 11,890,328 | Fibroin-derived protein composition In force · From the USPTO record | In force | From the USPTO record | |
| US 12,350,321 | Fibroin-derived protein composition In force · From the USPTO record | In force | From the USPTO record | |
| US 11,242,367 | Silk-Derived Protein for Treating Inflammation In force · High confidence | In force | High confidence |
Also on record, not counted in the 7: 1 patent in force now held by others. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending · 1 no status recorded